A Patient-Derived Xenograft Model of Glioblastoma

Glioblastoma (GBM) remains the most common malignant primary brain tumor in adults with a median survival of less than ~15 months. Further understanding and therapeutic development rely on the use of clinically relevant models of GBM. Here, we present our patient-derived in vitro and in vivo models...

Descripción completa

Detalles Bibliográficos
Autores principales: Chokshi, Chirayu R., Savage, Neil, Venugopal, Chitra, Singh, Sheila K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757408/
https://www.ncbi.nlm.nih.gov/pubmed/33377073
http://dx.doi.org/10.1016/j.xpro.2020.100179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757408/
https://www.ncbi.nlm.nih.gov/pubmed/33377073
http://dx.doi.org/10.1016/j.xpro.2020.100179

Ejemplares similares